Home About Us Services Markets Online Trading Back Office Contact Us Download Mutual Fund
BACK
Your are on :   Markets   |  IPO   |  IPO SynopsisAs on: Jul 02,2025 03:52 AM
Influx Healthtech Ltd
Registered Office: 109 Ghanshyam Enclave Premises,Co-Op Soc Plat #.856 Laljipada, Mumbai - 400067, Maharashtra, India.
Phone : +91 70459 97809   Fax:
Email :  cs@influxhealthtech.com  
Website :  www.influxhealthtech.com
Initial public offer of 61,00,800 equity shares of face value of Rs. 10/- each (the "Equity Shares") of Influx Heathtech Limited ("the Company" or "IHL" or "the Issuer") at an offer price of Rs. 96/- per equity share for cash, aggregating Rs. 58.57 crores ("Public Offer") comprising of a fresh offer of 50,00,400 equity shares aggregating to Rs. 48.00 crores (the "Fresh Offer") and an offer for sale of 11,00,400 equity shares by the promoter selling shareholder, Munir Abdul Ganee Chandniwala ("Offer for Sale") aggregating to Rs. 10.56 crores, (Hereinafter Refferd as "Promoter Selling Shareholder") out of which 3,06,000 equity shares of face value of Rs. 10/- each, at an offer price of Rs. 96/- per equity share for cash, aggregating Rs. 2.94 crores will be reserved for subscription by the market maker to the offer (the "Market Maker Reservation Portion"). The public offer less market maker reservation portion i.e. offer of 57,94,800 equity shares of face value of Rs. 10/- each, at an offer price of Rs. 96/- per equity share for cash, aggregating Rs. 55.63 crores is herein after referred to as the "Net Offer". The public offer and net offer will constitute 26.35 % and 25.03 % respectively of the post-offer paid-up equity share capital of the company.
Issue Money Payable On
Opens On Closes On Application Allotment
18-Jun-25 20-Jun-25 96.00-0.00 0.00-0.00
Minimum Application for shares in Nos : 1200   Further Multiples of : 1200
  (Rs) Lead Managers to the Issue
Project Cost 42.17 Rarever Financial Advisors Pvt Ltd
Project Financed through Current Offer 58.57  
Post Issue Equity Share Capital 23.15  
Issue Price 96.00  
Projects
Funding capital expenditure requirements for setting up of manufacturing facility for Nutraceutical Division Funding capital expenditure requirements for setting up of manufacturing facility for Veterinary Food Division
Purchase of Machineries for Homecare and Cosmetics Division General Corporate Expenses
Promoted By
Munir Abdul Ganee Chandniwala
Shirin Munir Ahmed Chandniwala
Abdul Ganee Abdul Rasul Chandn
Listing At
NSE - SME
Registrar to the Issue
No Data Available
Product Disclaimer Mandatory Information Privacy Policy Careers Risk disclosures Feedback Scores 2.0 Member Bank Details
"Investor Grievance" Mail your Grievance to info@lalkar.in
Important Links:   SEBI  |  NSE  |  BSE  |  MCX-SX  |  MCX   |   NCDEX  |  NSDL  |  CDSL  |  FMC   |   CDSL E-Voting  |  SMART ODR|  Saa₹thi  |  View Client Collateral Details  |  
Vernacular Languages  |  Online Freezing/Blocking Account  |  Advisory for Investor
SEBI REGISTRATION NOS - BSE CASH: INZ000269434  |  BSE FNO: INZ000269434  |  NSE CASH: INZ000269434  |  NSE FNO: INZ000269434  |  NSE CD: INZ000269434  |  MSEI CASH: INZ000269434   |   MSEI FNO: INZ000269434   |   MSEI CD: INZ000269434
AMFI NO : ARN- 19226
2010 © Lalkar Group. All rights reserved Designed, developed & powered by CMOTS Infotech(ISO 9001:2015 certified)